Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aerie Pharmaceuticals
(NQ:
AERI
)
16.81
USD
+0.31 (+1.88%)
Official Closing Price
Updated: 7:42 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Aerie Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Aerie Pharmaceuticals Receives European Commission Approval for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%
January 11, 2021
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Analysts Predict 15% Upside For The Holdings of IHE
January 07, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Bullish Two Hundred Day Moving Average Cross - AERI
December 15, 2020
In trading on Tuesday, shares of Aerie Pharmaceuticals Inc (AERI) crossed above their 200 day moving average of $13.09, changing hands as high as $13.12 per share. Aerie Pharmaceuticals Inc shares are...
Tags
Stocks
From
Market News Video
First Week of AERI January 2021 Options Trading
December 10, 2020
Investors in Aerie Pharmaceuticals Inc (AERI) saw new options begin trading this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AERI...
Tags
Stocks
From
Market News Video
The Math Shows IHE Can Go To $210
December 07, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Roclanda® in the European Union
November 13, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Aerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference
November 10, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Aerie Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
November 05, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
November 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
KOD
ATRS
SAGE
From
Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ...
Tags
ANIK
HBIO
AMPH
From
Benzinga
Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
October 29, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries
October 28, 2020
Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive development and commercialization...
From
Business Wire News Releases
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call on Thursday, November 5, 2020
October 27, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
RHHBY
Benzinga
News
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 21, 2020
Before 10 a.m. ET on Wednesday, 21 companies set new 52-week lows. Noteables: Equity Commonwealth (NYSE: EQC) was the ...
Tags
Market News
HPR
DSSI
From
Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
XTLB
LH
INSM
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 20, 2020
Before 10 a.m. ET Tuesday, 14 stocks made new 52-week lows. Significant Points: The company with the largest market ...
Tags
PRQR
TTNP
AERI
From
Benzinga
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
October 20, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
PACB
GILD
APTX
From
Benzinga
58 Biggest Movers From Yesterday
October 20, 2020
Gainers Kaixin Auto Holdings (NASDAQ: KXIN) shares climbed 293.7% to close at $8.15 on Monday after climbing over 55% on Friday. ...
Tags
AERI
SMMC
RWLK
From
Benzinga
Mid-Afternoon Market Update: Dow Falls 250 Points; BioSpecifics Technologies Shares Spike Higher
October 19, 2020
Toward the end of trading Monday, the Dow traded down 0.90% to 28348.53 while the NASDAQ fell 0.92% to 11564.13. The S&P also fell, ...
Tags
HAL
LAC
RESI
From
Benzinga
10 Healthcare Stocks Moving In Monday's Intraday Session
October 19, 2020
Gainers BOQI International (NASDAQ:BIMI) stock increased by 60.05% to $3.1 during Monday's regular session. Trading volume for ...
Tags
CNTG
PCSA
Top Gainers
From
Benzinga
Mid-Day Market Update: Front Yard Residential Surges Following Buyout Deal; American Equity Shares Plunge
October 19, 2020
Midway through trading Monday, the Dow traded down 0.22% to 28543.59 while the NASDAQ fell 0.08% to 11662.62. The S&P also fell, ...
Tags
Penny Stocks
Commodities
Eurozone
From
Benzinga
41 Stocks Moving In Monday's Mid-Day Session
October 19, 2020
Gainers Kaixin Auto Holdings (NASDAQ: KXIN) shares jumped 200% to $6.21 after climbing over 55% on Friday. JP Morgan, last week, ...
Tags
Internet Software & Services
NLS
FLUX
From
Benzinga
Why Aerie Pharmaceuticals Is Trading Lower Today
October 19, 2020
Aerie Pharmaceuticals (NASDAQ: AERI) shares are trading lower on Monday after Bank of America downgraded the stock from Neutral to ...
Tags
Downgrades
Benzinga
AERI
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 19, 2020
On Monday morning, 17 companies achieved new lows for the year. Significant Points: The company with the largest ...
Tags
Market News
GILD
CPIX
From
Benzinga
Benzinga's Top Upgrades, Downgrades For October 19, 2020
October 19, 2020
Upgrades According to Guggenheim, the prior rating for Bristol-Myers Squibb Company (NYSE: BMY) was changed from Neutral to Buy. ...
Tags
PAG
top upgrades
Analyst Ratings
From
Benzinga
Analysts Anticipate SMMV To Hit $33
October 05, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aerie Pharmaceuticals Announces Acceptance of Its Investigational New Drug Application for AR-15512 (TRPM8 Agonist) Eye Drop for Dry Eye Disease
September 29, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
September 26, 2020
Biotech stock reversed course lastweek, dragged lower by the broader market weakness. The week's news flow was headlined by ...
Tags
FDA
CAPR
IPOs
From
Benzinga
3 Top Mid-Cap Stocks to Buy Right Now
September 24, 2020
Investors would be wise to steer clear of the bigger, more mainstream names until the recent volatility has run its course
Tags
REGN
RHHB/Y
AERI
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.